1. Nio M, Wada M, Sasaki H, Tanaka H. Effects of age
at Kasai portoenterostomy on the surgical outcome: a review of the
literature. Surg Today. 2015;45:813-8.
2. Fawaz R, Baumann U, Ekong U, Fischler B,
Hadzic N, Mack CL, et al. Guideline for the evaluation of
cholestatic jaundice in infants: Joint recommendations of the North
American Society for Pediatric Gastroenterology, Hepatology, and
Nutrition and the European Society for Pediatric Gastroenterology,
Hepatology, and Nutrition. J Pediatric Gastroenterol Nut.
2017;64:154-68.
3. Matthai J, Paul S. Evaluation of cholestatic
jaundice in young infants. Indian Pediatr. 2001;38:893-8.
4. Nayak NC, Vasdev N. Neonatal cholestasis syndrome:
Identifying the disease from liver biopsy. Indian Pediatr.
2002;39:421-5.
55. Yang JG, Ma DQ, Peng Y, Song L, Li CL. Comparison
of different diagnostic methods for differentiating biliary atresia from
idiopathic neonatal hepatitis. Clin Imaging. 2009;33:439-46.
6. Ranjani H, Mehreen TS, Pradeepa R, Anjana RM, Garg
R, Anand K, et al. Epidemiology of childhood overweight and
obesity in India: A systematic review. Indian J Med Res.
2016;143:160-74.
7. Schwimmer JB. Clinical advances in pediatric
nonalcoholic fatty liver disease. Hepatology. 2016;63:1718-25.
8. Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M,
Feldstein AE, et al. Combined paediatric NAFLD fibrosis index and
transient elastography to predict clinically significant fibrosis in
children with fatty liver disease. Liver Int. 2013;33:79-85.
9. Bartlett JA, Sanchez LG, Kabbany MN, Shah J,
Mittal N, Alkhouri N, i>et al. The use of liver biopsy to determine
the severity of nonalcoholic fatty liver disease in children across the
United States. Proceedings of the NASPGHAN Annual Meeting; 2019 October
17-19, Chicago, IL. J Pediatr Gastroenterol Nutr. 2019; 69: S1-437.
10. Ascher Bartlett J.M., Mittal N, et al. A Single
Center Assessment of the 2017 NASPGHAN guidelines regarding liver biopsy
in the diagnosis of NASH in pediatric patients. Proceedings of the
NASPGHAN Annual Meeting; October 24-27, 2018, Hollywood, Fl
11. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC,
Smith AD, American Association for the study of liver diseases. Liver
biopsy. Hepatology. 2009;49:1017-44.
12. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L,
Holmqvist M, Bodemar G, et al. Long-term follow-up of patients
with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865-73.
13. Campbell MS, Reddy KR. Review article: the
evolving role of liver biopsy. Aliment Pharmacol Ther. 2004;20:249-59.
14. Pokorska-Spiewak M, Kowalik-Mikolajewska B,
Aniszewska M, Pluta M, Marczynska M. Is liver biopsy still needed in
children with chronic viral hepatitis? World J Gastroenterol.
2015;21:12141-9.
15. Schwarz KB, Rosenthal P, Murrary KF,Honegger JR,
Hardikar W, Mittal N, et al. Ledipasvir-Sofosbuvir for 12 Weeks
in Children 3 to <6 Years Old With Chronic Hepatitis C. Hepatology.
2020;71:422-30.
16. Mieli-Vergani G, Heller S, Jara P, Vergani D,
Chang MH, Fujisawa T, et al. Autoimmune hepatitis. J Pediatr
Gastroenterol Nutr. 2009;49:158-64.
17. Haas JE, Feusner JH, Finegold MJ. Small cell
undifferentiated histology in hepatoblastoma may be unfavorable. Cancer.
2001;92:3130-4.
18. Verma S, Gunuwan B, Mendler M, Govindrajan S,
Redeker A. Factors predicting relapse and poor outcome in type I
autoimmune hepatitis: Role of cirrhosis development, patterns of
transaminases during remission and plasma cell activity in the liver
biopsy. Am J Gastroenterol. 2004;99:1510-6.
19. Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P,
Lacaille F, et al. Management of chronic hepatitis B in
childhood: ESPGHAN clinical practice guidelines: Consensus of an expert
panel on behalf of the European Society of Pediatric Gastroenterology,
Hepatology and Nutrition. J Hepatol. 2013;59:814-29.
20. Hom X, Little NR, Gardner SD, Jonas MM.
Predictors of virologic response to Lamivudine treatment in children
with chronic hepatitis B infection. Pediatr Infect Dis J. 2004;23:441-5.
21. Jara P, Bortolotti F. Interferon-alpha treatment
of chronic hepatitis B in childhood: a consensus advice based on
experience in European children. J Pediatr Gastroenterol Nutr.
1999;29:163-70.
22. Chapin CA, Mohammad S, Bass LM, Taylor SA, Kelly
S, Alonso EM. Liver biopsy can be safely performed in pediatric acute
liver failure to aid in diagnosis and management. J Pediatr
Gastroenterol Nutr. 2018;67:441-5.
23. Pasha T, Gabriel S, Therneau T, Dickson ER,
Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy.
Hepatology. 1998;27:1220-6.
24. Mogahed EA, Mansy YA, Al Hawi Y, El-Sayed R, El-Raziky
M, El-Karaksy H. Blind percutaneous liver biopsy in infants and
children: Comparison of safety and efficacy of percussion technique and
ultrasound assisted technique. Arab J Gastroenterol. 2016;17:168-75.
25 Kader HA, Bellah R, Maller ES, Mamula P, Piccoli
DA, Markowitz JE. The utility of ultrasound site selection for pediatric
percutaneous liver biopsy. J Pediatr Gastroenterol Nutr. 2003;36:364-7.
26. Sherman KE, Goodman ZD, Sullivan ST, Faris-Young
S, Group GS. Liver biopsy in cirrhotic patients. Am J Gastroenterol.
2007;102:789-93.
27. Yoshimatsu R, Yamagami T, Tanaka O, Miura H,
Tanaka T, Suzuki T, et al. Comparison of fully automated and
semi-automated biopsy needles for lung biopsy under CT fluoroscopic
guidance. Br J Radiol. 2012;85:208-13.
28. Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas
JM, Gross JB, et al. The role of ultrasonography and
automatic-needle biopsy in outpatient percutaneous liver biopsy.
Hepatology. 1996;23:1079-83.
29. Garcia-Compean D, Cortes C. Transjugular liver
biopsy. An update. Ann Hepatol. 2004;3:100-3.
30. Cholongitas E, Quaglia A, Samonakis D, Senzolo M,
Triantos C, Patch D, et al. Transjugular liver biopsy: how good
is it for accurate histological interpretation? Gut. 2006;55:1789-94.
31. Srivastava A, Prasad D, Panda I, Yadav R, Jain M,
Sarma MS, et al. Transjugular Versus Percutaneous Liver Biopsy in
Children: Indication, Success, Yield, and Complications. J Pediatr
Gastroenterol Nutr. 2020;70:417-22.
32. Vajro P, Hadchouel P, Hadchouel M, Bernard O,
Alagille D. Incidence of cirrhosis in children with chronic hepatitis. J
Pediatr. 1990;117:392-6.
33. Dezsofi A, Baumann U, Dhawan A, Durmaz O,
Fischler B, Hadzic N, et al. Liver biopsy in children: Position
paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr.
2015;60:408-20.
34. Matos H, Noruegas MJ, Goncalves I, Sanches C.
Effectiveness and safety of ultrasound-guided percutaneous liver biopsy
in children. Pediatr Radiol. 2012;42:1322-5.
35. Kozlovich SY, Sochet AA, Son S, Wilsey MJ.
Same-day versus overnight observation after outpatient pediatric
percutaneous liver biopsy: A retrospective cohort study. Pediatr
Gastroenterol Hepatol Nutr. 2019;22:377-86.
36. Almeida P, Schreiber RA, Liang J, Mujawar Q,
Guttman OR. Clinical characteristics and complications of pediatric
liver biopsy: A single centre experience. Ann Hepatol. 2017;16:797-801.
37. Cohen MB, HH AK, Lambers D, Heubi JE.
Complications of percutaneous liver biopsy in children.
Gastroenterology. 1992;102:629-32.
38. Westheim BH, Ostensen AB, Aagenaes I, Sanengen T,
Almaas R. Evaluation of risk factors for bleeding after liver biopsy in
children. J Pediatr Gastroenterol Nutr. 2012;55:82-7.
39. Tulin-Silver S, Obi C, Kothary N, Lungren MP.
Comparison of transjugular liver biopsy and percutaneous liver biopsy
with tract embolization in pediatric patients. J Pediatr Gastroenterol
Nutr. 2018;67:180-4.
40. Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine
JE. Liver biopsy in modern clinical practice: a pediatric point-of-view.
Adv Anat Pathol. 2012;19:250-62.
41. Bolia R, Matta J, Malik R, Hardikar W. Outpatient
liver biopsy in children: safety, feasibility, and economic impact. J
Pediatr Gastroenterol Nutr. 2017;65:86-8.
42. Crawford AR, Lin XZ, Crawford JM. The normal
adult human liver biopsy: A quantitative reference standard. Hepatology.
1998;28:323-31.
43. Bilreiro C, Noruegas MJ, Goncalves I, Moreira A.
Ultrasound-guided liver biopsies in children: A single-center experience
and risk factors for minor bleeding. J Pediatr Gastroenterol Nutr.
2017;65:137-40.
44. Bejarano PA, Koehler A, Sherman KE. Second
opinion pathology in liver biopsy interpretation. Am J Gastroenterol.
2001;96:3158-64.
45. Poddar U, Shava U, Yachha SK, Agarwal J, Kumar S,
Baijal SS, et al. Beta-blocker therapy ameliorates hypersplenism
due to portal hypertension in children. Hepatol Int. 2015;9:447-53.
46. Xu H, Cai R. Avatrombopag for the treatment of
thrombocytopenia in patients with chronic liver disease. Expert Rev Clin
Pharmacol. 2019;12:859-65.